
0.6558 Delayed Data As of Mar 31 | ![]() Today’s Change | 0.64 Today|||52-Week Range 18.95 | -56.28% Year-to-Date |
Previous close | 0.70 |
Today’s open | 0.69 |
Day’s range | 0.65 - 0.69 |
Volume | 1,790 |
Average volume (3 months) | 621,454 |
Market cap | $3.9M |
Earnings growth (last year) | +66.02% |
Earnings growth (this year) | +27.16% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | +1,618.56% |
P/E ratio | NM |
Price/Sales | 0.61 |
Price/Book | 0.28 |
Today’s change | Today’s % change | |
---|---|---|
PLXPPLx Pharma Inc | -0.01 | -8.27% |
---- | ||
QLGNQualigen Therapeutic... | +0.00 | +0.45% |
--Orphazyme A/S | 0.00 | 0.00% |
Next reporting date | May 11, 2023 |
EPS forecast (this quarter) | -$1.65 |
Annual revenue (last year) | $6.9M |
Annual profit (last year) | -$21.1M |
Net profit margin | -303.93% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boulder, Colorado |